Christopher Bruno

IP & Appellate Lawyer. Avid Traveler & Points Accumulator. Home Gardener Wannabe. Novice Sailor, All-Around Problem Solver (but no advice here!).

[Christopher Bruno @ChrisBrunoJD]

I'm very pleased to post that for the first time, I've been ranked in the IAM Patent 1000 -- Bronze Band in DC for Patent Litigation! The most important recognition I receive is from my clients and colleagues, but I'm happy to share the stage with 23 othe…https://t.co/LfSliKylAh

[Christopher Bruno @ChrisBrunoJD]

All,

A follow up on my post re: the PREVAIL act. Check out the Law360 analysis. Selfish interest: I had a few thoughts (maybe a hot take or two) that made their way in!

#iplaw #iplitigation #mwe #ptab #patentlaw https://t.co/TBlloSrbRr

[Christopher Bruno @ChrisBrunoJD]

Along with co-panelist @LSmalley_HB, I'll be unpacking some major issues in #patent #damages: restrictions on methodologies, foreign sales, use of experts, and best practices.

Join me if you can.

#iplaw #patentlaw #patentdamages https://t.co/F9k9HTQu5M

[Christopher Bruno @ChrisBrunoJD]

Two big pieces of #IP #legislation recently introduced.

The first, offered by Senator Coons, the PREVAIL Act (https://t.co/y6oM0s9JKy), makes significant changes to the current #PTAB practice, including overruling the Fintiv discretionary denial rule, re…https://t.co/T6kWT0Hkvm

[Christopher Bruno @ChrisBrunoJD]

This. https://t.co/3K3kecMHM0

[Christopher Bruno @ChrisBrunoJD]

Interesting precedential opinion out of the Federal Circuit today in UCB v. Actavis. On anticipation, it succinctly summarizes the difference between overlapping-range anticipation and point-in-range anticipation.

#iplaw #patentlaw #federalcircuit https://t.co/ZAYg9CwCC9

[Christopher Bruno @ChrisBrunoJD]

Where was I this morning? In a room where it happens, watching the Amgen v. Sanofi #supremecourt argument about the #enablement test with my partner (and one of the lawyers on the case) Sarah Columbia.

This makes 5 #patent SCOTUS cases I’ve watched in pe…https://t.co/s1BgjCCMT4

[Christopher Bruno @ChrisBrunoJD]

Am incredibly important topic, and one we don’t talk about enough in the #legal profession. Whether you know it or not, you probably work with #neurodivergent colleagues all the time. I know I do, and it comes with both special challenges and rich rewards…https://t.co/23lZ4FxqNG

[Christopher Bruno @ChrisBrunoJD]

Just ran across this #lifesciences #pharma #IP director position -- looks like an interesting one! https://t.co/8cBZYxQgoz

[Christopher Bruno @ChrisBrunoJD]

Fresh out of the Federal Circuit today, a decision affirming an order requiring a brand manufacturer to delist an erroneously listed patent. The patent covered a computer system to comply with REMS requirements. A lot to unpack her…https://t.co/eCcSiAvgXh https://t.co/KpjV7obGXs

[Christopher Bruno @ChrisBrunoJD]

A bunch of clever litigants who lose at the #ptab have tried to use Arthrex as a springboard for new, related challenges. The #federalcircuit has largely rejected them. Read my article on the latest in the trend.

#iplaw #iplitigation #patents #patentlaw https://t.co/mJfLNaGphh

[Christopher Bruno @ChrisBrunoJD]

Interesting article, and a problem to keep an eye on. https://t.co/Tr9QL2jNJB

[Christopher Bruno @ChrisBrunoJD]

When I finished trial a few months ago, I posted about how fulfilling the experience was, and how appreciative I was for my team and client. Last week, I saw the fruits of our hard work reflected in the Court's 77-page opinion siding with our client Bausc…https://t.co/9Nw43BzftL

[Christopher Bruno @ChrisBrunoJD]

The IP cert grants keep coming… maybe a Section 101 case next?

#iplaw #iplitigation #trademarklaw #scotus https://t.co/IKSWdUa0he

[Christopher Bruno @ChrisBrunoJD]

Good morning! For those in my ANDAsphere, I woke up to an interesting decision from Judge Andrews (D.Del.) to share. When a generic company converts from a Paragraph IV certification to a section viii carving out a method of use, t…https://t.co/W3lm56TuXQ https://t.co/K6np4xdHwm

[Christopher Bruno @ChrisBrunoJD]

Most times I post about IP law. But now that I’ve gotten my sleep and my vacation in, it’s time to throw out a recent professional victory. The success isn’t the outcome of a three-day Hatch-Waxman #pharmaceutical #patent #infringement bench trial I just…https://t.co/3fMOwYPdHy

[Prof. Dennis Crouch ⚖️ Patent Law & AI @patentlyo]

Chart below shows the number of disclaimed US patents each year. The numbers for 2022 are off-the-charts. Can someone help me understand what is happening here?

[Christopher Bruno @ChrisBrunoJD]

Happy Friday everyone! For those who follow all the legal scuttle about the appointments of #PTAB judges, here's my take on the latest move by the #FederalCircuit.

#iplaw #patentlaw https://t.co/7fRUFpnftP

[Christopher Bruno @ChrisBrunoJD]

One of my life goals is to own a small vacation home in Colombia. Maybe there’s a career path for me after, all, Nasheed Amin-Bruno, M.S.Ed.

#iplaw https://t.co/MuLLrxMyKW

[Christopher Bruno @ChrisBrunoJD]

For my #HatchWaxman colleagues, ICYMI: The #FederalCircuit reaffirmed that the #ANDA specification controls, absent evidence that the real-world product will deviate upon production, for Section 271(e). But it also provided an exam…https://t.co/QkNfDgQv7r https://t.co/FzZDbB0fST